Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model. - Stringer, Megan; Abeysekera, Irushi; Dria, Karl J.; Roper, Randall J.; Goodlett, Charles R. (Pharmacology, Biochemistry & Behavior, 2015)